MET and cancer: beta-catenin could explain the acquisition of a more aggressive, highly invasive, phenotype, upon c-Met activation, likely controlling the amount of cancer cells showing stem-like properties, reported to be associated with acquired chemoresistance, spreading and higher metastatic potential [42, 21].